Molecular imaging parameters, such as PSMA total tumor volume and average standardized uptake value (SUVmean) on PSMA-PET have been associated with overall survival and treatment response to LuPSMA therapy [3, 4]. This evidence concerns the gene FOLH1 and neoplasm.